nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

28.11.2022 | Original Article

Clinical features of type 1 and type 2 diabetes patients with suspected fungal foot infections: a single-center experience

verfasst von: Selda Celik, Elif Bagdemir, Sevim Purisa, Ayse Kubat Uzum, Ilhan Satman, Gulsah Yenidunya Yalin

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Background/aim

Fungal foot infections are common and increase the risk of diabetic foot ulcers (DFU) in patients with diabetes. We aimed to investigate the clinical features and related risk factors in type 1 and type 2 diabetes mellitus patients with suspected fungal feet infection (SFFI) in an outpatient setting.

Methods

This is a single center, cross-sectional study. A total of 816 patients with diabetes patients were included in this study. Patients were divided into two groups according to the presence of clinical SFFI (group 1; SFFI ( +); n = 487 and group 2; SFFI (-); n = 329). Groups were compared in terms of demographic characteristics, disease information (type and duration of diabetes, diabetes treatment, presence of retinopathy, nephropathy, neuropathy, DFU, and hypertension), HbA1c level, daily foot care activities (frequency of foot washing, keeping toes dry after washing, religious habits, etc.), and skin condition.

Results

Signs of SFFI were detected in 59.7% of the patients. Type 2 diabetes, insulin treatment, female sex, and skin dryness were significantly more common among patients with SFFI (p = 0. 000, 0.005,0.013, and 0.000, respectively). Religious habits and social lifestyle were not significantly different between groups (p = 0.109 and 0.703, respectively). Retinopathy, neuropathy, and hypertension were more prevalent in patients with SFFI (p = 0.006, 0.012, and 0.001, respectively). SFFI correlated with age and dryness of skin (OR:0.024, 95% CI: 0.959–0.993, p = 0.007; OR: 1.094, 95% CI: 2.484–3.589, p = 0.000 respectively).

Conclusion

Patients at risk of SFFI should be educated about regular nail and skin care, including prevention of dry skin conditions for early prevention of subsequent diabetic foot problems.

Saeedi P, Petersohn I, Salpea P. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from IDF Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.CrossRefPubMed

Raspovic KM, Wukich DK. Self reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53:716–9. https://doi.org/10.1053/j.jfas.2014.06.011.CrossRefPubMed

Lipsky BA, Aragón-Sánchez J, Diggle M. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl. 1):45–74. https://doi.org/10.1002/dmrr.2699.CrossRefPubMed

Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus A case-control study. Ann Intern Med. 1992;117:97–105. https://doi.org/10.7326/0003-4819-117-2-97.CrossRefPubMed

Winston JA, Miller JL. Treatment of onychomycosis in diabetic patients. Clin Diabetes. 2006;24:160–6.CrossRef

Romano C, Massai L, Asta F. Prevalence of dermatophytic skin and nail infections in diabetic patients. Mycoses. 2001;44:83–6. https://doi.org/10.1046/j.1439-0507.2001.00624.x.CrossRefPubMed

Powers AC, Stafford MJ, Rickels MR. Diabetes mellitus: complications. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J. Harrison‘s Principles of internal medicine. 20th Ed., New York: McGraw-Hill, 2018; 2:2882.

Gupta AK, Konnikov N, MacDonald P. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139:665–71. https://doi.org/10.1046/j.1365-2133.1998.02464.x.CrossRefPubMed

Stiegler H. Diabetic foot syndrome. Herz. 2004;29:104–15. https://doi.org/10.1007/s00059-004-2534-z.CrossRefPubMed

10.

Rich P, Hare A. Onychomycosis in a special patient population: focus on the diabetic. Int J Dermatol. 1999;38(2):17–9. https://doi.org/10.1046/j.1365-4362.1999.00009.x.CrossRefPubMed

11.

Bokyo WL, Doyle JJ, Ryu S. PDD5: Onychomycosis and its impact on secondary infection development in the diabetic population. Value Health. 1999;2(3):199.

12.

Mayfield JA, Sugarman JR. Use of Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(11):17–29.

13.

Meijer JW, Smit AJ, Lefrandt JD. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care. 2005;28:2201–5. https://doi.org/10.2337/diacare.28.9.2201.CrossRefPubMed

14.

Bouhassira D, Attal N, Alchaar H. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36. https://doi.org/10.1016/j.pain.2004.12.010.CrossRefPubMed

15.

Oz Y, Qoraan I, Oz A. Prevalence and epidemiology of tinea pedis and toenailonychomycosis and antifungal susceptibility of the causativeagents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56(1):68–74. https://doi.org/10.1111/ijd.13402.CrossRefPubMed

16.

Peleg A, Weerarathna T, McCarthy JS. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23:3–13. https://doi.org/10.1002/dmrr.682.CrossRefPubMed

17.

Dogra S, Kumar B, Bhansali A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol. 2002;41:647–51. https://doi.org/10.1046/j.1365-4362.2002.01528.x.CrossRefPubMed

18.

Raboobee N, Aboobaker J, Peer AK. Tinea pedis et unguium in the Muslim community of Durban. South Africa Int J Dermatol. 1998;37:759–65. https://doi.org/10.1046/j.1365-4362.1998.00550.x.CrossRefPubMed

19.

Ilkit M, Tanir F, Hazar S. Epidemiology of tinea pedis and toenail tinea unguium in worshippers in the mosques in Adana. Turkey J Dermatol. 2005Sep;32(9):698–704. https://doi.org/10.1111/j.1346-8138.2005.tb00828.x.CrossRefPubMed

20.

Litzelman DK, Marriott DJ, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Conventional wisdom or evidence-based practice? Diabetes Care. 1997;20:156–62. https://doi.org/10.2337/diacare.20.2.156.CrossRefPubMed

21.

American Diabetes Association. 11 Microvascular complications and foot care: Standards of Medical Care in Diabetes 2021. Diabetes Care. 2021;44(Suppl. 1):151–67. https://doi.org/10.2337/dc21-S011.CrossRef

22.

Celik S, Yenidunya G, Temel E. Utility of DN4 questionnaire in assessment of neuropathic pain and its clinical correlations in Turkish patients with diabetes mellitus. Prim Care Diabetes. 2016;10(4):259–64. https://doi.org/10.1016/j.pcd.2015.11.005.CrossRefPubMed

23.

Gupta AK, Gupta MA, Summerbell RC. Epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol. 2000;14:466–9. https://doi.org/10.1046/j.1468-3083.2000.00124.x.CrossRefPubMed

24.

Bristow I. Non-ulcerative skin pathologies of the diabetic foot. Diabetes Metab Res Rev. 2008;24(Suppl 1):84–9. https://doi.org/10.1002/dmrr.818.CrossRef

25.

Vinik AI, Maser RE, Mitchell BD. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79. https://doi.org/10.2337/diacare.26.5.1553.CrossRefPubMed

26.

Pham HT, Exelbert L, Segal-Owens AC. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage. 2002;48:30–6.PubMed

Titel: Clinical features of type 1 and type 2 diabetes patients with suspected fungal foot infections: a single-center experience
verfasst von: Selda Celik
Elif Bagdemir
Sevim Purisa
Ayse Kubat Uzum
Ilhan Satman
Gulsah Yenidunya Yalin
Publikationsdatum: 28.11.2022
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 5/2023
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-022-01147-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Clinical features of type 1 and type 2 diabetes patients with suspected fungal foot infections: a single-center experience

Abstract

Background/aim

Methods

Results

Conclusion

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background/aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

The suitability, acceptability, and feasibility of a culturally contextualized low-calorie diet among women at high risk for diabetes mellitus in Kerala: a mixed-methods study

TNF-α levels, hypertension, glycated hemoglobin, and lower limb pain are predictors of diabetic neuropathy

Effect of glycemic control and duration of type 2 diabetes on circulatory miR-146a in middle-aged Indians

Relationship between insulin-biochemical resistance levels and the degree of depression and anxiety in patients from Honduras

A study to evaluate the knowledge, vaccination status and acceptance of adult vaccinations against respiratory infections in patients with type 2 diabetes in South India

Screen for DPN—save limbs and lives!